Empirical therapy advisor
Before culture results are back: how likely is each antibiotic to cover the pathogen of a patient like this one, in this ward, given the last 12 months of results and today's alerts.
Based on 400 first isolates · MED-B · Cystitis (lower UTI) · 2024-02-25 → 2025-02-23
Internal medicine BNarrowest option reaching 80 % coverage, no active warning
nitrofurantoin 81 % (77 %–85 %)
No tissue or blood levels: cystitis only.
Not covered: Proteus mirabilis (8 %), Klebsiella pneumoniae (5 %), Pseudomonas aeruginosa (5 %)
AntibioticCoverage, 12 months (95 % CI)12 mo4 wk
Most likely organisms for this profile
Escherichia coli
55 %
Enterococcus faecalis
11 %
Klebsiella pneumoniae
10 %
Proteus mirabilis
8 %
Klebsiella oxytoca
5 %
Pseudomonas aeruginosa
5 %
Decision support only: coverage is the share of first isolates from similar patients that were susceptible (an organism not tested for a drug counts as not covered). It does not replace local treatment guidelines, allergy and severity assessment, or clinical judgement. The black tick on each bar is the coverage target; the bracket is the 95 % confidence interval.